News
20h
Yen on MSNOzempic-maker Novo Nordisk says CEO to step downDanish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Novo Nordisk CEO Lars Fruergaard Jørgensen will step down after eight years at the helm, as the Danish pharmaceutical giant ...
May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...
6h
Barchart on MSNJim Cramer Says You Should Buy This ‘Strong Buy’ Stock ‘Hand Over Fist’Eli Lilly (LLY) is a leading pharmaceutical company that discovers, develops, manufactures, and markets healthcare products.
On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...
Novo Nordisk has filed another Citizen's Petition ... once-weekly drugs like semaglutide-based Ozempic and Wegovy – used for diabetes and obesity – the once-daily product still made more ...
Novo Nordisk shares gained on expectations that competition for its blockbuster obesity shot Wegovy will subside later this year. The stock rose as much as ...
It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results